Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giorgio Inghirami

Showing results (121-130 of 239) with videos related to

Pageof 24
Sort By:
Blood|December 10, 2014
Integrin αvβ3 acting as membrane receptor for thyroid hormones mediates angiogenesis in malignant T cellsFlorencia Cayrol, María Celeste Díaz Flaqué, Tharu Fernando, et al.
Biorxiv : the Preprint Server for Biology|February 23, 2026
CAR-T Targeting of Mutant Calreticulin Establishes a Potentially Curative Stem Cell-Directed Therapy for Myeloproliferative NeoplasmsDaniel C Choi, Giovanni Medico, Irina V Lebedeva, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|April 28, 2019
Whole exome sequencing reveals mutations in FAT1 tumor suppressor gene clinically impacting on peripheral T-cell lymphoma not otherwise specifiedMaria Antonella Laginestra, Luciano Cascione, Giovanna Motta, et al.
Molecular Cancer Therapeutics|December 29, 2011
CEP-28122, a highly potent and selective orally active inhibitor of anaplastic lymphoma kinase with antitumor activity in experimental models of human cancersMangeng Cheng, Matthew R Quail, Diane E Gingrich, et al.
Blood|August 9, 2013
Deregulation of ETS1 and FLI1 contributes to the pathogenesis of diffuse large B-cell lymphomaPaola Bonetti, Monica Testoni, Marta Scandurra, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 12, 2014
ALK/EML4 fusion gene may be found in pure squamous carcinoma of the lungAnna Caliò, Alessia Nottegar, Eliana Gilioli, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|September 28, 2019
Correction: Whole exome sequencing reveals mutations in FAT1 tumor suppressor gene clinically impacting on peripheral T-cell lymphoma not otherwise specifiedMaria Antonella Laginestra, Luciano Cascione, Giovanna Motta, et al.
Human Pathology|February 8, 2018
Cell of origin markers identify different prognostic subgroups of lung adenocarcinomaFabrizio Tabbò, Alessia Nottegar, Francesco Guerrera, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 28, 2015
The BET Bromodomain Inhibitor OTX015 Affects Pathogenetic Pathways in Preclinical B-cell Tumor Models and Synergizes with Targeted DrugsMichela Boi, Eugenio Gaudio, Paola Bonetti, et al.
Blood|September 29, 2023
Spatial mapping of human hematopoiesis at single-cell resolution reveals aging-associated topographic remodelingAleksandr Sarachakov, Arina Varlamova, Viktor Svekolkin, et al.
Pageof 24

Showing results (121-130 of 239) with videos related to

Sort By:
Pageof 24
Blood|December 10, 2014
Integrin αvβ3 acting as membrane receptor for thyroid hormones mediates angiogenesis in malignant T cellsFlorencia Cayrol, María Celeste Díaz Flaqué, Tharu Fernando, et al.
Biorxiv : the Preprint Server for Biology|February 23, 2026
CAR-T Targeting of Mutant Calreticulin Establishes a Potentially Curative Stem Cell-Directed Therapy for Myeloproliferative NeoplasmsDaniel C Choi, Giovanni Medico, Irina V Lebedeva, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|April 28, 2019
Whole exome sequencing reveals mutations in FAT1 tumor suppressor gene clinically impacting on peripheral T-cell lymphoma not otherwise specifiedMaria Antonella Laginestra, Luciano Cascione, Giovanna Motta, et al.
Molecular Cancer Therapeutics|December 29, 2011
CEP-28122, a highly potent and selective orally active inhibitor of anaplastic lymphoma kinase with antitumor activity in experimental models of human cancersMangeng Cheng, Matthew R Quail, Diane E Gingrich, et al.
Blood|August 9, 2013
Deregulation of ETS1 and FLI1 contributes to the pathogenesis of diffuse large B-cell lymphomaPaola Bonetti, Monica Testoni, Marta Scandurra, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 12, 2014
ALK/EML4 fusion gene may be found in pure squamous carcinoma of the lungAnna Caliò, Alessia Nottegar, Eliana Gilioli, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|September 28, 2019
Correction: Whole exome sequencing reveals mutations in FAT1 tumor suppressor gene clinically impacting on peripheral T-cell lymphoma not otherwise specifiedMaria Antonella Laginestra, Luciano Cascione, Giovanna Motta, et al.
Human Pathology|February 8, 2018
Cell of origin markers identify different prognostic subgroups of lung adenocarcinomaFabrizio Tabbò, Alessia Nottegar, Francesco Guerrera, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 28, 2015
The BET Bromodomain Inhibitor OTX015 Affects Pathogenetic Pathways in Preclinical B-cell Tumor Models and Synergizes with Targeted DrugsMichela Boi, Eugenio Gaudio, Paola Bonetti, et al.
Blood|September 29, 2023
Spatial mapping of human hematopoiesis at single-cell resolution reveals aging-associated topographic remodelingAleksandr Sarachakov, Arina Varlamova, Viktor Svekolkin, et al.
Pageof 24